EUVIMEDEUVIMED entdecken
Crossref

DeepSide: A Deep Learning Approach for Drug Side Effect Prediction

Onur Can Uner, Halil Ibrahim Kuru, R Gokberk Cinbis, Oznur Tastan, A Ercument Cicek

IEEE/ACM Transactions on Computational Biology and Bioinformatics · 01.01.2023 · 20 (1) · 330-339

DOI: 10.1109/tcbb.2022.3141103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IEEE/ACM Transactions on Computational Biology and Bioinformatics, erschienen am 01.01.2023. Verfasst von Onur Can Uner und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Deep Learning, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: TUBA - GEBIP 2017 Award, Bilim Akademisi BAGEP 2020 Award, TUSEB Aziz Sancar Reseach Incentive 2020 Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug failures due to unforeseen adverse effects at clinical trials pose health risks for the participants and lead to substantial financial losses. Side effect prediction algorithms have the potential to guide the drug design process. LINCS L1000 dataset provides a vast resource of cell line gene expression data perturbed by different drugs and creates a knowledge base for context specific features. The state-of-the-art approach that aims at using context specific information relies on only the high-quality experiments in LINCS L1000 and discards a large portion of the experiments. In this study, our goal is to boost the prediction performance by utilizing this data to its full extent. We experiment with 5 deep learning architectures. We find that a multi-modal architecture produces the best predictive performance among multi-layer perceptron-based architectures when drug chemical structure (CS), and the full set of drug perturbed gene expression profiles (GEX) are used as modalities. Overall, we observe that the CS is more informative than the GEX. A convolutional neural network-based model that uses only SMILES string representation of the drugs achieves the best results and provides 13.0% macro-AUC and 3.1% micro-AUC improvements over the state-of-the-art. We also show that the model is able to predict side effect-drug pairs that are reported in the literature but was missing in the ground truth side effect dataset. DeepSide is available at http://github.com/OnurUner/DeepSide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep LearningDrug-Related Side Effects and Adverse ReactionsHumansNeural Networks, ComputerAlgorithmsCell Line

Förderung

  • TUBA - GEBIP 2017 Award
  • Bilim Akademisi BAGEP 2020 Award
  • TUSEB Aziz Sancar Reseach Incentive 2020 Award

Zitieren

APA

Uner, O. C., Kuru, H. I., Cinbis, R. G., Tastan, O., & Cicek, A. E. (2023). DeepSide: A Deep Learning Approach for Drug Side Effect Prediction. IEEE/ACM Transactions on Computational Biology and Bioinformatics, 20(1), 330-339. https://doi.org/10.1109/tcbb.2022.3141103

Vancouver

Uner OC, Kuru HI, Cinbis RG, Tastan O, Cicek AE. DeepSide: A Deep Learning Approach for Drug Side Effect Prediction. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 2023;20(1):330-339. doi:10.1109/tcbb.2022.3141103

BibTeX
@article{Uner2023,
  author = {Uner, Onur Can and Kuru, Halil Ibrahim and Cinbis, R Gokberk and Tastan, Oznur and Cicek, A Ercument},
  title = {DeepSide: A Deep Learning Approach for Drug Side Effect Prediction},
  journal = {IEEE/ACM Transactions on Computational Biology and Bioinformatics},
  year = {2023},
  volume = {20},
  number = {1},
  pages = {330--339},
  doi = {10.1109/tcbb.2022.3141103}
}
Kostenlos starten →